Tanner M, Hohorst A, Westerman J, Mendoza C, Han R, Moya N
Neurobiol Learn Mem. 2024; 212:107937.
PMID: 38735637
PMC: 11187715.
DOI: 10.1016/j.nlm.2024.107937.
Cain C
Curr Top Behav Neurosci. 2023; 64:19-57.
PMID: 37532965
PMC: 10840073.
DOI: 10.1007/7854_2023_434.
Shelkar G, Liu J, Dravid S
Int J Neuropsychopharmacol. 2021; 24(11):907-919.
PMID: 34363482
PMC: 8598288.
DOI: 10.1093/ijnp/pyab055.
Faucher C, Doherty R, Philip N, Harle A, Cole J, Vant Wout-Frank M
Behav Neurosci. 2021; 135(6):702-713.
PMID: 34338547
PMC: 8648962.
DOI: 10.1037/bne0000487.
Reyes-Garcia S, Escobar M
Front Cell Neurosci. 2021; 15:685838.
PMID: 34220454
PMC: 8242195.
DOI: 10.3389/fncel.2021.685838.
GluN2B and GluN2A-containing NMDAR are differentially involved in extinction memory destabilization and restabilization during reconsolidation.
Radiske A, Gonzalez M, Noga D, Rossato J, Bevilaqua L, Cammarota M
Sci Rep. 2021; 11(1):186.
PMID: 33420399
PMC: 7794413.
DOI: 10.1038/s41598-020-80674-7.
Sex differences in the effects of a combined behavioral and pharmacological treatment strategy for cocaine relapse prevention in an animal model of cue exposure therapy.
Kantak K, Gauthier J, Mathieson E, Knyazhanskaya E, Rodriguez-Echemendia P, Man H
Behav Brain Res. 2020; 395:112839.
PMID: 32750464
PMC: 7492466.
DOI: 10.1016/j.bbr.2020.112839.
Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder.
Hofmann S, Papini S, Carpenter J, Otto M, Rosenfield D, Dutcher C
PLoS One. 2019; 14(10):e0223729.
PMID: 31622374
PMC: 6797442.
DOI: 10.1371/journal.pone.0223729.
Randomized controlled trial of d-cycloserine in cocaine dependence: Effects on contingency management and cue-induced cocaine craving in a naturalistic setting.
Johnson M, Bruner N, Johnson P, Silverman K, Berry M
Exp Clin Psychopharmacol. 2019; 28(2):157-168.
PMID: 31368770
PMC: 6994347.
DOI: 10.1037/pha0000306.
Sign-tracking behavior is difficult to extinguish and resistant to multiple cognitive enhancers.
Fitzpatrick C, Geary T, Creeden J, Morrow J
Neurobiol Learn Mem. 2019; 163:107045.
PMID: 31319166
PMC: 6773616.
DOI: 10.1016/j.nlm.2019.107045.
Acute and long-lasting effects of oxytocin in cortico-limbic circuits: consequences for fear recall and extinction.
Triana-Del Rio R, van den Burg E, Stoop R, Hegoburu C
Psychopharmacology (Berl). 2018; 236(1):339-354.
PMID: 30302511
DOI: 10.1007/s00213-018-5030-5.
Running from fear: Exercise modulation of fear extinction.
Tanner M, Hake H, Bouchet C, Greenwood B
Neurobiol Learn Mem. 2018; 151:28-34.
PMID: 29614374
PMC: 6557445.
DOI: 10.1016/j.nlm.2018.03.021.
A return to the psychiatric dark ages with a two-system framework for fear.
Fanselow M, Pennington Z
Behav Res Ther. 2017; 100:24-29.
PMID: 29128585
PMC: 5794606.
DOI: 10.1016/j.brat.2017.10.012.
Low-dose systemic scopolamine disrupts context conditioning in rats.
Luyten L, Nuyts S, Beckers T
J Psychopharmacol. 2017; 31(6):667-673.
PMID: 28417664
PMC: 5462095.
DOI: 10.1177/0269881117699614.
Ketamine accelerates fear extinction via mTORC1 signaling.
Girgenti M, Ghosal S, Lopresto D, Taylor J, Duman R
Neurobiol Dis. 2017; 100:1-8.
PMID: 28043916
PMC: 5907920.
DOI: 10.1016/j.nbd.2016.12.026.
Voluntary exercise during extinction of auditory fear conditioning reduces the relapse of fear associated with potentiated activity of striatal direct pathway neurons.
Mika A, Bouchet C, Bunker P, Hellwinkel J, Spence K, Day H
Neurobiol Learn Mem. 2015; 125:224-35.
PMID: 26454156
PMC: 4648665.
DOI: 10.1016/j.nlm.2015.10.001.
An Overview of Translationally Informed Treatments for Posttraumatic Stress Disorder: Animal Models of Pavlovian Fear Conditioning to Human Clinical Trials.
Bowers M, Ressler K
Biol Psychiatry. 2015; 78(5):E15-27.
PMID: 26238379
PMC: 4527085.
DOI: 10.1016/j.biopsych.2015.06.008.
Implications of learning theory for developing programs to decrease overeating.
Boutelle K, Bouton M
Appetite. 2015; 93:62-74.
PMID: 25998235
PMC: 4654402.
DOI: 10.1016/j.appet.2015.05.013.
Epigenetics and memory: causes, consequences and treatments for post-traumatic stress disorder and addiction.
Pizzimenti C, Lattal K
Genes Brain Behav. 2015; 14(1):73-84.
PMID: 25560936
PMC: 4526190.
DOI: 10.1111/gbb.12187.
Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.
Singewald N, Schmuckermair C, Whittle N, Holmes A, Ressler K
Pharmacol Ther. 2015; 149:150-90.
PMID: 25550231
PMC: 4380664.
DOI: 10.1016/j.pharmthera.2014.12.004.